DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

BSE Limited — Updates

NSE 1 hr ago·19 Aug 2026, 2:03 pm

BSE

BSE Limited has announced plans to launch new derivatives products in India that will be linked to MSCI indexes. This move aims to broaden the range of investment tools available to traders and investors by providing exposure to international market benchmarks through a local platform.

For investors, this development is significant as it could enhance BSE's competitiveness against other exchanges. By offering these specific derivatives, BSE hopes to attract more trading volumes and solidify its position in the financial market ecosystem.

Investors should monitor the regulatory approvals and the actual launch timeline for these new products. Keeping an eye on the trading volumes and the market response will be crucial to understanding the long-term impact of this strategic expansion.